Literature DB >> 27677384

Interactions between peroxiredoxin 2, hemichrome and the erythrocyte membrane.

Simone B Bayer1, Felicia M Low1, Mark B Hampton1, Christine C Winterbourn1.   

Abstract

Peroxiredoxin 2 (Prx2) is an abundant antioxidant protein in erythrocytes that protects against hemolytic anemia resulting from hemoglobin oxidation and Heinz body formation. A small fraction of Prx2 is bound to the cell membrane, but the mechanism and relevance of binding are not clear. We have investigated Prx2 interactions with the erythrocyte membrane and oxidized hemoglobin and whether these interactions are dependent on Prx2 redox state. Membrane binding of Prx2 in erythrocytes decreased when the cells were treated with H2O2, but studies with purified Prx2 and isolated ghosts showed that the interaction was independent of Prx2 redox state. Hemoglobin oxidation leads to the formation of hemichrome, a denatured form of the protein that binds to Band3 protein in the cell membrane as part of the senescence process and is a precursor of Heinz bodies. Hemichrome competed with Prx2 and decreased Prx2 binding to the membrane, potentially explaining the decreased binding in oxidant-exposed cells. The increased membrane binding of Prx2 seen with increasing intracellular calcium was less sensitive to H2O2 or hemichrome, suggesting an alternative mode of binding. Prx2 was also shown to exhibit chaperone-like activity by retarding the precipitation of pre-formed hemichrome. Our results suggest that Prx2, by restricting membrane binding of hemichrome, could impede Band3 clustering and exposure of senescence antigens. This mechanism, plus the observed chaperone activity for oxidized hemoglobin, may help protect against hemolytic anemia.

Entities:  

Keywords:  Antioxidant defense; Heinz body; chaperone; hemoglobin oxidation; phenylhydrazine

Mesh:

Substances:

Year:  2016        PMID: 27677384     DOI: 10.1080/10715762.2016.1241995

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  8 in total

1.  Innate Variability in Physiological and Omics Aspects of the Beta Thalassemia Trait-Specific Donor Variation Effects.

Authors:  Alkmini T Anastasiadi; Vassilis L Tzounakas; Monika Dzieciatkowska; Vasiliki-Zoi Arvaniti; Effie G Papageorgiou; Issidora S Papassideri; Konstantinos Stamoulis; Angelo D'Alessandro; Anastasios G Kriebardis; Marianna H Antonelou
Journal:  Front Physiol       Date:  2022-06-08       Impact factor: 4.755

2.  Syk Kinase Inhibitors Synergize with Artemisinins by Enhancing Oxidative Stress in Plasmodium falciparum-Parasitized Erythrocytes.

Authors:  Ioannis Tsamesidis; Karine Reybier; Giuseppe Marchetti; Maria Carmina Pau; Patrizia Virdis; Claudio Fozza; Francoise Nepveu; Philip S Low; Francesco Michelangelo Turrini; Antonella Pantaleo
Journal:  Antioxidants (Basel)       Date:  2020-08-14

3.  The mechanism of formation, structure and physiological relevance of covalent hemoglobin attachment to the erythrocyte membrane.

Authors:  Elizabeth M Welbourn; Michael T Wilson; Ashril Yusof; Metodi V Metodiev; Chris E Cooper
Journal:  Free Radic Biol Med       Date:  2016-12-20       Impact factor: 7.376

4.  Global analysis of erythroid cells redox status reveals the involvement of Prdx1 and Prdx2 in the severity of beta thalassemia.

Authors:  Karen S Romanello; Karina K L Teixeira; João Pedro M O Silva; Sheila T Nagamatsu; Marcos André C Bezerra; Igor F Domingos; Diego A P Martins; Aderson S Araujo; Carolina Lanaro; Carlos A Breyer; Regiane A Ferreira; Carla Franco-Penteado; Fernando F Costa; Iran Malavazi; Luis E S Netto; Marcos A de Oliveira; Anderson F Cunha
Journal:  PLoS One       Date:  2018-12-06       Impact factor: 3.240

5.  Peroxiredoxin2 (Prdx2) Reduces Oxidative Stress and Apoptosis of Myocardial Cells Induced by Acute Myocardial Infarction by Inhibiting the TLR4/Nuclear Factor kappa B (NF-κB) Signaling Pathway.

Authors:  Hangshun Li; Haina Yang; Dandan Wang; Lixin Zhang; Tao Ma
Journal:  Med Sci Monit       Date:  2020-12-03

Review 6.  The Effect of Sepsis on the Erythrocyte.

Authors:  Ryon M Bateman; Michael D Sharpe; Mervyn Singer; Christopher G Ellis
Journal:  Int J Mol Sci       Date:  2017-09-08       Impact factor: 5.923

7.  Unveiling the Physical and Functional Niches of FAM26F by Analyzing Its Subcellular Localization and Novel Interacting Partners.

Authors:  Uzma Malik; Saima Zafar; Neelam Younas; Inga Zerr; Aneela Javed
Journal:  ACS Omega       Date:  2020-08-25

Review 8.  Peroxiredoxins in Cancer and Response to Radiation Therapies.

Authors:  Tom E Forshaw; Reetta Holmila; Kimberly J Nelson; Joshua E Lewis; Melissa L Kemp; Allen W Tsang; Leslie B Poole; W Todd Lowther; Cristina M Furdui
Journal:  Antioxidants (Basel)       Date:  2019-01-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.